Anti-c1s antibody

TW202631665APending Publication Date: 2026-08-01CHUGAI PHARMA CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2022-04-14
Publication Date: 2026-08-01

Application Information

Patent Timeline

14 Apr 2022

Application

01 Aug 2026

Publication

TW202631665A

IPC: C07K16/18; A61K39/395; A61P29/00; A61P35/00; A61P37/00

Inventors: 古賀光

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure 00000000_0000_ABST

Patent Text Reader

Abstract

This invention provides a pH-dependent binding C1s antibody comprising an antigen-binding region and an antibody constant region. The invention further provides a pharmaceutical composition containing any of these antibodies, and a method for treating an individual with a complement-mediated disease or disorder, or a method for preventing such disease or disorder, by administering any of these antibodies to an individual.

Need to check novelty before this filing date? Find Prior Art